A CLOSED SYSTEM FOR PATHOGEN REDUCTION OF RED BLOOD CELLS FOR TRANSFUSION

NIH RePORTER · NIH · R44 · $1,169,287 · view on reporter.nih.gov ↗

Key facts

NIH application ID
10126895
Project number
5R44HL145783-03
Recipient
ZATA PHARMACEUTICALS, INC.
Principal Investigator
David R Tabatadze
Activity code
R44
Funding institute
NIH
Fiscal year
2021
Award amount
$1,169,287
Award type
5
Project period
2019-03-01 → 2023-02-28